Romero Syndrome
Romero Syndrome is a rare and severe neurodegenerative disease first identified on V25. It is characterised by its slow progression, irreversible neurological damage, and the absence of any known curative treatment. The disease has since become one of the most closely monitored long-term health threats in Quadrant 7 due to the later emergence of a far more dangerous variant.
Initial symptoms typically include subtle motor impairment, reduced fine motor control, and mild cognitive decline. Over time, sufferers experience worsening coordination loss, memory impairment, and personality flattening. In advanced stages, patients develop near-total paralysis accompanied by profound cognitive degradation, requiring full-time care. Progression is generally measured in years rather than weeks or months.
The origin of Romero Syndrome remains unknown. Extensive investigation has failed to identify a definitive viral, bacterial, or parasitic cause. No evidence of genetic engineering has been confirmed, and prevailing theories range from prion-like agents to complex neurochemical or environmental triggers unique to V25.
A mutated and significantly more aggressive variant, known as Romero27, later emerged on Flash Peek. Unlike the original syndrome, Romero27 is associated with extreme behavioural instability, uncontrolled violence, severe physiological mutation, and rapid onset, transforming the disease from a chronic medical tragedy into an acute security threat.
Countermeasures for Romero Syndrome are limited to supportive and palliative care, neurological monitoring, and strict containment protocols for the Romero-27 strain. Within Quadrant Health Organisation doctrine, Romero Syndrome is regarded as a stark example of how poorly understood neurological diseases can evolve into existential risks without warning.





